Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer

Gastric cancer (GC) is the fifth most common malignant neoplasm in the world among all malignant tumors. Currently, the “gold” standard of treatment for patients with non‑metastatic cancer of the stomach and esophageal–gastric junction is surgical treatment, which is complemented by perioperative ch...

ver descrição completa

Detalhes bibliográficos

Principais autores:	M. V. Sedova, M. A. Batov, V. S. Tretyak, A. A. Kolomeytseva, V. M. Khomyakov, N. N. Volchenko, A. A. Fedenko, A. D. Kaprin
Formato:	Artigo
Idioma:	Russo
Publicado em:	QUASAR, LLC 2023-06-01
coleção:	Исследования и практика в медицине
Assuntos:	gastric cancer perioperative chemotherapy immunotherapy target therapy
Acesso em linha:	https://www.rpmj.ru/rpmj/article/view/920
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!